Literature DB >> 11964985

Calvarial bone distraction with a contractile bioresorbable polymer.

José Guimarães-Ferreira1, Fredrik Gewalli, Lisa David, Giovanni Maltese, Harri Heino, Claes Lauritzen.   

Abstract

The aim of the present study was to evaluate the possibility of mobilizing calvarial bone with a fully implantable and bioresorbable device. The animal model used was the New Zealand white rabbit (n = 12). An island bone flap attached to the dura mater was created in the parietal region and amalgam markers were placed in this bone flap and in the ipsilateral frontal bone. In one group of six rabbits (group 1), a specially processed contractile 70L/30D,L polylactic acid plate, 15 x 6 x 0.6 mm, was attached to the island flap by one extremity, and to the fixed ipsilateral frontal bone by the other. In group 2 (control), no plate was added. Bone marker movement was followed with serial radiography. In group 1, there was a progressive reduction in mean marker distance over the first 48 hours, and stability thereafter. In group 2 (control), mean marker distance remained stable until the second postoperative week, after which time there was a slight increase until the end of the experimental period. At 4 weeks, the mean marker separation differed significantly between group 1 (mean, -3.62 mm; SD, 0.79 mm) and group 2 (mean, 0.34 mm; SD, 0.14 mm; p <0.001). In conclusion, a totally implantable and bioresorbable device was successfully used to mobilize calvarial bone. Polymer contractility will likely constitute the basis of a new generation of bioresorbable distractors for use in craniofacial surgery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11964985     DOI: 10.1097/00006534-200204010-00017

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  1 in total

1.  Programmed water-induced shape-memory of bioabsorbable poly(D,L-lactide): activation and properties in physiological temperature.

Authors:  K Paakinaho; H Heino; M Pelto; M Hannula; P Törmälä; M Kellomäki
Journal:  J Mater Sci Mater Med       Date:  2011-12-28       Impact factor: 3.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.